Marsh & Mclennan Companies (MMC) 57.86 $MMC Marsh &

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Marsh & Mclennan Companies (MMC) 57.86 $MMC

Marsh & McLennan Companies Names Ferdinand G. Jahnel Vice President, Treasurer
Business Wire - Fri Mar 20, 6:30AM CDT
Marsh & McLennan Companies, Inc. (NYSE:MMC), a global professional services firm offering clients advice and solutions in risk, strategy, and people, today announced that Ferdinand G. Jahnel has been appointed Vice President, Treasurer, reporting to Senior Vice President of Corporate Finance, Mark McGivney, effective April 1, 2015.
MMC: 57.86 (+0.35)

Marsh & McLennan Companies Names Maria Silvia Bastos Marques to Board of Directors
Business Wire - Thu Mar 19, 2:15PM CDT
Marsh & McLennan Companies, Inc. (NYSE:MMC), a global professional services firm offering clients advice and solutions in risk, strategy, and people, announced today that Maria Silvia Bastos Marques has been elected to the Company's Board of Directors, effective immediately. Ms. Marques will also stand for election at the Company's upcoming annual meeting of shareholders on May 21, 2015.
MMC: 57.86 (+0.35)

Marsh & McLennan declares $0.28 dividend
Seeking Alpha - at Seeking Alpha - Wed Mar 18, 10:40AM CDT

MMC: 57.86 (+0.35)

Marsh & McLennan Companies Declares Quarterly Dividend
Business Wire - Wed Mar 18, 10:30AM CDT
The Board of Directors of Marsh & McLennan Companies, Inc. (NYSE:MMC) today declared a quarterly dividend of $.28 per share on outstanding common stock, payable on May 15, 2015, to shareholders of record on April 10, 2015.
MMC: 57.86 (+0.35)

Marsh & McLennan Companies Names Dina Shapiro Vice President, Head of Tax
Business Wire - Tue Mar 17, 4:30PM CDT
Marsh & McLennan Companies, Inc. (NYSE:MMC), a global professional services firm offering clients advice and solutions in risk, strategy, and people, today announced that Dina Shapiro has been appointed Vice President, Head of Tax, reporting to Marsh & McLennan Companies Chief Financial Officer Mike Bischoff, effective March 30, 2015. Ms. Shapiro will be based at Marsh & McLennan Companies' corporate headquarters in New York City.
MMC: 57.86 (+0.35)

ACE's Unit Prices $800M Senior Notes, Sees Rating Action - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 11, 2:20PM CDT
ACE INA Holdings Inc., a subsidiary of ACE Limited (ACE) is offering 3.15% $800 million senior notes due Mar 2025. A.M. Best and Moody's assign ratings to the notes.
ACE: 113.54 (-0.14), AFL: 63.89 (+0.80), MMC: 57.86 (+0.35), MCO: 104.26 (+1.79)

AFLAC Issues $1 Billion Senior Notes, Moody's Favors - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 10, 1:30PM CDT
AFLAC Inc. (AFL) announced the pricing of senior notes worth $550 million and $450 million due to mature in 2020 and 2025 respectively.
ACE: 113.54 (-0.14), AFL: 63.89 (+0.80), MMC: 57.86 (+0.35), MCO: 104.26 (+1.79)

The Conference Board and Mercer Announce Strategic Collaboration to Launch Workforce Analytics Institute
PR Newswire - Sun Mar 08, 9:00PM CDT
The Conference Board and Mercer are pleased to announce the launch of the Workforce Analytics Institute (WAI) - the first of its kind in Asia.
MMC: 57.86 (+0.35)

Lincoln National (LNC) Raises New Debt, Ratings Unaffected - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 06, 3:40PM CST
Lincoln National Corp. (LNC) issued 10-year notes worth $300 million.
MET: 51.62 (+1.01), LNC: 58.22 (+0.86), KMPR: 39.83 (+0.69), MMC: 57.86 (+0.35)

Insurance Brokers Face Further Commoditization
Ryan Edward - at Seeking Alpha - Fri Mar 06, 8:22AM CST

BRO: 33.13 (+0.30), WSH: 49.17 (-0.02), AJG: 47.64 (+0.05), AON: 99.30 (+0.39), MMC: 57.86 (+0.35)

Marsh & McLennan Issues $500M Notes, Moody's Favors - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 05, 1:20PM CST
Marsh & McLennan Cos. Inc. (MMC) priced five-year fixed rate senior unsecured notes worth $500 million.
AON: 99.30 (+0.39), ERIE: 89.90 (+2.10), MMC: 57.86 (+0.35), MCO: 104.26 (+1.79)

Why Benefitfocus, Inc Is Soaring Today
Todd Campbell, The Motley Fool - Motley Fool - Thu Mar 05, 11:59AM CST
Source: Benefitfocus Although we don't believe in   timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What's happening: Two days after...
ICA: 3.54 (+0.13), BNFT: 39.22 (+0.92), MMC: 57.86 (+0.35)

Arthur J Gallagher Announces Three Acquisitions in a Row - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 05, 11:10AM CST
Arthur J Gallagher & Co. (AJG) entered Mar 2015 with a hat trick of acquisitions. The insurance broker announced the acquisition of Illinois-based retail insurance broker NationAir Aviation Insurance, on Tuesday.
BRO: 33.13 (+0.30), WSH: 49.17 (-0.02), AJG: 47.64 (+0.05), MMC: 57.86 (+0.35)

Some Companies Are More Wonderful Than Others
Investing Doc - at Seeking Alpha - Sun Mar 01, 4:02AM CST

BBT: 39.81 (+0.25), MON: 115.75 (+0.37), EA: 57.28 (+1.32), HSY: 102.09 (+1.54), ED: 61.47 (+0.63), SYY: 38.62 (+0.42), LM: 58.27 (+1.36), INTC: 31.31 (+0.57), UPS: 100.25 (+0.34), PGR: 27.65 (+0.12), BSX: 17.84 (+0.03), SPY: 210.41 (+0.91), JPM: 61.75 (+0.55), COF: 81.13 (+0.51), FII: 33.61 (+0.75), DE: 89.18 (+1.10), LOW: 75.23 (+0.67), MSFT: 42.88 (+0.60), ROK: 116.15 (+1.65), CSCO: 28.44 (+0.18), MA: 89.82 (+0.80), SYK: 93.65 (+0.08), BCS: 15.32 (+0.35), BCR: 171.48 (+0.79), ISCA: 32.25 (+0.36), RNR: 101.01 (+0.10), PFE: 34.25 (+0.10), WFC: 56.01 (+0.50), MO: 51.42 (+0.15), ISRG: 509.03 (+0.27), CPB: 45.75 (+0.45), SHW: 290.00 (+5.51), CVX: 107.03 (+2.28), INTU: 100.43 (+0.65), ADSK: 60.98 (-0.02), NVS: 101.68 (+1.81), GD: 135.41 (+0.13), MMM: 166.49 (+0.83), BDX: 144.72 (-0.21), GE: 25.40 (+0.07), CHRW: 75.40 (+0.24), CLX: 111.89 (+2.30), MDT: 78.02 (+0.36), BLK: 378.64 (+8.69), KMB: 108.48 (+1.73), C: 52.98 (+0.60), KEY: 14.65 (+0.22), MMC: 57.86 (+0.35), JNJ: 102.40 (+0.71), CME: 99.75 (+0.08), CINF: 54.60 (+0.81), PPG: 229.06 (+2.89), BMO: 60.54 (+1.36), FITB: 19.48 (+0.26), HD: 117.49 (+2.33), WU: 19.20 (-0.05), GGG: 72.18 (-1.10), EMR: 56.69 (+0.42), BMY: 67.76 (-0.56), CTAS: 82.55 (-1.41), JOE: 18.01 (+0.43), USB: 44.86 (+0.42), PG: 84.74 (+1.36), IGT: 17.86 (+0.08), BEN: 53.35 (+0.69), CMCSA: 59.45 (+0.71), MXIM: 36.19 (+0.41), RF: 9.64 (+0.14), MKC: 72.88 (+0.48), UTX: 119.46 (+0.08), MTB: 128.00 (+1.54), WMT: 83.24 (+1.72), GOOG: 560.36 (+2.37), SLB: 82.37 (+1.36), SLM: 9.27 (-0.01), TGT: 81.31 (+0.71), LYG: 4.85 (+0.14), FWRD: 57.57 (+1.84), CLMS: 12.79 (+0.03), STR: 23.91 (+0.27), AVP: 7.63 (+0.35), STT: 76.24 (+1.41), VFC: 75.25 (+1.19), LLTC: 48.53 (+0.94), IRM: 38.65 (+0.38), MHFI: 108.59 (+1.08), FDO: 79.90 (+0.20), GSK: 48.81 (+0.60), TIF: 82.93 (-3.44), ADP: 87.77 (+0.40), WBA: 88.23 (+0.87), SIAL: 138.20 (+0.11), MRK: 58.58 (+0.37), EXPD: 49.27 (+0.40), MCD: 97.05 (+1.07), DOV: 71.30 (+0.16), BRK.B: 145.53 (+0.65), WTW: 8.60 (-0.81), CTL: 35.30 (+0.44), BIIB: 475.98 (+42.33), LMT: 203.77 (+1.58), XOM: 84.54 (+0.13), PEP: 95.34 (+1.24), TWX: 87.89 (+1.06), SWK: 96.32 (+0.45), SBUX: 97.46 (-0.30), PAYX: 51.62 (+0.38), FAST: 42.30 (-0.17), EBAY: 57.93 (+0.05), QCOM: 70.04 (+0.21), DIA: 180.96 (+1.30), SNV: 28.31 (+0.60), AVY: 53.49 (+0.49), SNY: 50.64 (+1.17), BK: 40.57 (+0.27), HRB: 32.90 (+0.61), KO: 40.65 (+0.63), AXP: 82.70 (+1.16), SVU: 11.33 (+0.09), NUE: 47.14 (+1.04), LEG: 46.42 (+0.32), AMGN: 170.10 (+0.99), DIS: 108.43 (+1.06), BAC: 15.84 (+0.23), ORCL: 44.41 (+0.25), BRO: 33.13 (+0.30), JCI: 50.40 (+0.64), CL: 69.56 (+1.27)

Marsh & McLennan: A Unique Play In The Risk Management Business
Andy Batts - at Seeking Alpha - Fri Feb 27, 10:58AM CST

MMC: 57.86 (+0.35)

Willis Group Strengthens Indian Base with Almondz Insurance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 25, 4:41PM CST
Willis Group Holdings Public Limited Company (WSH) inked a deal to purchase 49% stake in a leading Indian insurance broker, Almondz Insurance Brokers Private Limited.
BRO: 33.13 (+0.30), WSH: 49.17 (-0.02), AJG: 47.64 (+0.05), MMC: 57.86 (+0.35)

Why Shares of Benefitfocus Inc. Exploded Higher Today
Timothy Green, The Motley Fool - Motley Fool - Wed Feb 25, 12:21PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Benefitfocus , a provider of cloud-based...
BNFT: 39.22 (+0.92), MMC: 57.86 (+0.35)

Arthur J Gallagher Gains on Cohn Financial Acquisition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 19, 4:25PM CST
Arthur J Gallagher & Co. (AJG) declared the acquisition of Arizona-based private placement life insurance distributor Cohn Financial Group, LLC.
BRO: 33.13 (+0.30), WSH: 49.17 (-0.02), AJG: 47.64 (+0.05), MMC: 57.86 (+0.35)

Upgrade Alert for Marsh & McLennan (MMC)
Comtex SmarTrend(R) - Wed Feb 18, 7:02AM CST
Marsh & McLennan (NYSE:MMC) was upgraded from Neutral to Buy at Citigroup today. The stock closed yesterday at $56.51 on volume of 2.9 million shares, above average daily volume of 2.3 million. Marsh & McLennan Companies, Inc. is a global professional services firm providing advice and solutions in the areas of risk, strategy and human capital. Marsh & McLennan offers analysis, advice, and transactional capabilities to clients worldwide
MMC: 57.86 (+0.35)

Everest Names Jonathan Zaffino as President of Everest National Insurance Company / U.S. Insurance Operations
Business Wire - Tue Feb 17, 12:31PM CST
Everest Re Group, Ltd. (NYSE:RE) announced today that Jonathan M. Zaffino will be joining the Company as President of Everest National Insurance Company / U.S. Insurance Operations. Mr. Zaffino assumes his new role effective immediately.
RE: 177.09 (+0.99), MMC: 57.86 (+0.35)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 316

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 0

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 291

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 406

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Stretch Zone Expands Horizons with Canadian Studio Launch

Updated Category News Views 214

Stretch Zone's Exciting New Chapter in Canada Stretch Zone, a trailblazer in the realm of assisted stretching, has embarked on a significant milestone by opening its first studio in Canada. This new location is not just a store but a powerful symbol of the brand's commitment to enhance flexibility and mobility in communities beyond the United States. The Vision Behind the...

Continue Reading
Eilean Therapeutics Unveils Groundbreaking JAK2 Inhibitor ZE74-0282

Updated Category News Views 585

New Frontiers in JAK2 Inhibition by Eilean Therapeutics Eilean Therapeutics LLC, a pioneering biotechnology company, is set to make waves in cancer treatment with its latest development, ZE74-0282, a wild-type-sparing JAK2-JH2/V617F inhibitor. The company has announced an exciting presentation at the upcoming American Society of Hematology (ASH) Annual Meeting, focusing...

Continue Reading
PodcastOne Extends LadyGang Contract as It Approaches 1000 Episodes

Updated Category News Views 116

PodcastOne Renews its Agreement with LadyGang Podcast PodcastOne, a key player in the podcasting world, is thrilled to announce the renewal of its contract with the immensely popular LadyGang podcast, hosted by Keltie Knight, Becca Tobin, and Jac Vanek. Launched in 2015 on PodcastOne, this engaging podcast has resonated with millions of listeners and is gearing up to...

Continue Reading
BCA Research Warns Upcoming Rate Cuts May Be Insufficient

Updated Category News Views 73

BCA Research Warns Rate Cuts May Arrive Too Late BCA Research has expressed concerns about the upcoming rate cuts, suggesting they might not effectively address a potential recession. The firm points out that the effects of monetary policy often lag, meaning the economy is still grappling with the repercussions of previous tightening measures. Market Sentiments and...

Continue Reading
SOMOS Pilates Nashville: A Vibrant Rebranding Journey

Updated Category News Views 235

SOMOS Pilates Nashville: A Vibrant Rebranding Journey In an inspiring shift, Studio Pilates Nashville has announced its rebranding as SOMOS Pilates Nashville. This transition marks a significant evolution, aimed at celebrating the studio's growth and commitment to community-centered movement practices. Welcoming a New Identity The rebranding initiative reveals more than...

Continue Reading